Pathways’ Pick of the Week
Pathways' Pick of the Week: Recruiting for AdComms
FDA seeks more advisory panelists. Excerpted from Pathways Picks September 30: Robot Evolution, Recruiting FDA Panelists, Global Medtech, and More.
Welcome to MyStrategist.
MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
ICYMI
Label Change for Ruptured AAAs
FDA approval of a labeling change that will allow Medtronic and Gore to help physicians learn to use stent grafts to treat ruptured abdominal aortic aneurysms. Excerpted from our recent feature article “Medtronic and Gore Break Through EVAR-Labeling Logjam.”
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with Market Pathways.
Subscribe Free Premier Issue Learn More
Regulatory & Reimbursement
Pathways' Pick of the Week: South Korea Eyes Novel Regulatory Routes for AI
MDFS announces its variation on staged approvals for AI. Excerpted from Pathways Picks September 16: TAVR Coverage, New AI Routes, Harmonization Actions, and More.
Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.
Subscribe Now Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: South Korea Eyes Novel Regulatory Routes for AI
MDFS announces its variation on staged approvals for AI. Excerpted from Pathways Picks September 16: TAVR Coverage, New AI Routes, Harmonization Actions, and More.